Review



biotin streptavidin fluorescent conjugates  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Vector Laboratories biotin streptavidin fluorescent conjugates
    Biotin Streptavidin Fluorescent Conjugates, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 2218 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotin streptavidin fluorescent conjugates/product/Vector Laboratories
    Average 96 stars, based on 2218 article reviews
    biotin streptavidin fluorescent conjugates - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    96
    Vector Laboratories biotin streptavidin fluorescent conjugates
    Biotin Streptavidin Fluorescent Conjugates, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotin streptavidin fluorescent conjugates/product/Vector Laboratories
    Average 96 stars, based on 1 article reviews
    biotin streptavidin fluorescent conjugates - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    99
    Thermo Fisher streptavidin peroxidase solution
    Streptavidin Peroxidase Solution, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/streptavidin peroxidase solution/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    streptavidin peroxidase solution - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    Vector Laboratories biotin streptavidin blocking solution
    Biotin Streptavidin Blocking Solution, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotin streptavidin blocking solution/product/Vector Laboratories
    Average 99 stars, based on 1 article reviews
    biotin streptavidin blocking solution - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher detection solution contained streptavidin alexa fluor 488
    Detection Solution Contained Streptavidin Alexa Fluor 488, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/detection solution contained streptavidin alexa fluor 488/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    detection solution contained streptavidin alexa fluor 488 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher dynabeads m 280 streptavidin solution
    Dynabeads M 280 Streptavidin Solution, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dynabeads m 280 streptavidin solution/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    dynabeads m 280 streptavidin solution - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher streptavidin hrp solution
    Streptavidin Hrp Solution, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/streptavidin hrp solution/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    streptavidin hrp solution - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    Miltenyi Biotec macs streptavidin beads solution
    2D validation of candidate peptides (A) Scheme depicts the bovine serum albumin (BSA) coating strategy for polystyrene culture dishes with subsequent peptide functionalization. After BSA activation with sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (Sulfo-SMCC), C-terminally thiolated peptides were covalently linked to the coating substrate. (B) LAMα1-p1 peptides that were N-terminally linked to a biotin molecule were used for the functionalization of BSA coating as described in (A) and subsequently detected with fluorophore-coupled <t>streptavidin</t> (green). Serum free myoblast growth medium was used as a vehicle control. Scale bar = 500 μm. (C and D) Schematic workflow (C) and quantification (D) of WT myoblast numbers 7 h after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (E and F) Schematic workflow (E) and quantification of WT myoblast numbers (F) ∼2.5 days after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (G) Percentage of KI67 positive WT myoblasts 2.5 days after plating on BSA-conjugated candidate peptides. (H and I) Schematic workflow (H) and quantification of LAMA2−/− myoblast numbers (I) ∼2.5 days after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (J) Percentage of KI67 positive LAMA2−/− myoblasts 2.5 days after plating on BSA-conjugated candidate peptides. Horizontal bars represent means ± sem from n = 4 (D,I,J) and n = 3 (F,G) biological replicates, each corresponding to an independent myoblast line isolated from a separate mouse. p values relative to the unconjugated BSA control were calculated using one-way ANOVA with Dunnett correction. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
    Macs Streptavidin Beads Solution, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/macs streptavidin beads solution/product/Miltenyi Biotec
    Average 99 stars, based on 1 article reviews
    macs streptavidin beads solution - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher streptavidin solution
    2D validation of candidate peptides (A) Scheme depicts the bovine serum albumin (BSA) coating strategy for polystyrene culture dishes with subsequent peptide functionalization. After BSA activation with sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (Sulfo-SMCC), C-terminally thiolated peptides were covalently linked to the coating substrate. (B) LAMα1-p1 peptides that were N-terminally linked to a biotin molecule were used for the functionalization of BSA coating as described in (A) and subsequently detected with fluorophore-coupled <t>streptavidin</t> (green). Serum free myoblast growth medium was used as a vehicle control. Scale bar = 500 μm. (C and D) Schematic workflow (C) and quantification (D) of WT myoblast numbers 7 h after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (E and F) Schematic workflow (E) and quantification of WT myoblast numbers (F) ∼2.5 days after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (G) Percentage of KI67 positive WT myoblasts 2.5 days after plating on BSA-conjugated candidate peptides. (H and I) Schematic workflow (H) and quantification of LAMA2−/− myoblast numbers (I) ∼2.5 days after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (J) Percentage of KI67 positive LAMA2−/− myoblasts 2.5 days after plating on BSA-conjugated candidate peptides. Horizontal bars represent means ± sem from n = 4 (D,I,J) and n = 3 (F,G) biological replicates, each corresponding to an independent myoblast line isolated from a separate mouse. p values relative to the unconjugated BSA control were calculated using one-way ANOVA with Dunnett correction. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
    Streptavidin Solution, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/streptavidin solution/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    streptavidin solution - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher streptavidin peroxidase solutions
    2D validation of candidate peptides (A) Scheme depicts the bovine serum albumin (BSA) coating strategy for polystyrene culture dishes with subsequent peptide functionalization. After BSA activation with sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (Sulfo-SMCC), C-terminally thiolated peptides were covalently linked to the coating substrate. (B) LAMα1-p1 peptides that were N-terminally linked to a biotin molecule were used for the functionalization of BSA coating as described in (A) and subsequently detected with fluorophore-coupled <t>streptavidin</t> (green). Serum free myoblast growth medium was used as a vehicle control. Scale bar = 500 μm. (C and D) Schematic workflow (C) and quantification (D) of WT myoblast numbers 7 h after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (E and F) Schematic workflow (E) and quantification of WT myoblast numbers (F) ∼2.5 days after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (G) Percentage of KI67 positive WT myoblasts 2.5 days after plating on BSA-conjugated candidate peptides. (H and I) Schematic workflow (H) and quantification of LAMA2−/− myoblast numbers (I) ∼2.5 days after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (J) Percentage of KI67 positive LAMA2−/− myoblasts 2.5 days after plating on BSA-conjugated candidate peptides. Horizontal bars represent means ± sem from n = 4 (D,I,J) and n = 3 (F,G) biological replicates, each corresponding to an independent myoblast line isolated from a separate mouse. p values relative to the unconjugated BSA control were calculated using one-way ANOVA with Dunnett correction. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
    Streptavidin Peroxidase Solutions, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/streptavidin peroxidase solutions/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    streptavidin peroxidase solutions - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    2D validation of candidate peptides (A) Scheme depicts the bovine serum albumin (BSA) coating strategy for polystyrene culture dishes with subsequent peptide functionalization. After BSA activation with sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (Sulfo-SMCC), C-terminally thiolated peptides were covalently linked to the coating substrate. (B) LAMα1-p1 peptides that were N-terminally linked to a biotin molecule were used for the functionalization of BSA coating as described in (A) and subsequently detected with fluorophore-coupled streptavidin (green). Serum free myoblast growth medium was used as a vehicle control. Scale bar = 500 μm. (C and D) Schematic workflow (C) and quantification (D) of WT myoblast numbers 7 h after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (E and F) Schematic workflow (E) and quantification of WT myoblast numbers (F) ∼2.5 days after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (G) Percentage of KI67 positive WT myoblasts 2.5 days after plating on BSA-conjugated candidate peptides. (H and I) Schematic workflow (H) and quantification of LAMA2−/− myoblast numbers (I) ∼2.5 days after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (J) Percentage of KI67 positive LAMA2−/− myoblasts 2.5 days after plating on BSA-conjugated candidate peptides. Horizontal bars represent means ± sem from n = 4 (D,I,J) and n = 3 (F,G) biological replicates, each corresponding to an independent myoblast line isolated from a separate mouse. p values relative to the unconjugated BSA control were calculated using one-way ANOVA with Dunnett correction. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

    Journal: iScience

    Article Title: Identification of skeletal muscle stem cell adhesion motifs using spot-synthesis-based peptide arrays

    doi: 10.1016/j.isci.2025.114498

    Figure Lengend Snippet: 2D validation of candidate peptides (A) Scheme depicts the bovine serum albumin (BSA) coating strategy for polystyrene culture dishes with subsequent peptide functionalization. After BSA activation with sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (Sulfo-SMCC), C-terminally thiolated peptides were covalently linked to the coating substrate. (B) LAMα1-p1 peptides that were N-terminally linked to a biotin molecule were used for the functionalization of BSA coating as described in (A) and subsequently detected with fluorophore-coupled streptavidin (green). Serum free myoblast growth medium was used as a vehicle control. Scale bar = 500 μm. (C and D) Schematic workflow (C) and quantification (D) of WT myoblast numbers 7 h after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (E and F) Schematic workflow (E) and quantification of WT myoblast numbers (F) ∼2.5 days after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (G) Percentage of KI67 positive WT myoblasts 2.5 days after plating on BSA-conjugated candidate peptides. (H and I) Schematic workflow (H) and quantification of LAMA2−/− myoblast numbers (I) ∼2.5 days after plating on BSA-conjugated candidate peptides. Values are expressed relative to BSA coating without peptide functionalization (BSA). (J) Percentage of KI67 positive LAMA2−/− myoblasts 2.5 days after plating on BSA-conjugated candidate peptides. Horizontal bars represent means ± sem from n = 4 (D,I,J) and n = 3 (F,G) biological replicates, each corresponding to an independent myoblast line isolated from a separate mouse. p values relative to the unconjugated BSA control were calculated using one-way ANOVA with Dunnett correction. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

    Article Snippet: After washing, the pellet was incubated with MACS streptavidin beads solution (1:200, 130-048-101, Miltenyi Biotec) for 1 h on ice.

    Techniques: Biomarker Discovery, Activation Assay, Control, Isolation

    In vivo peptide delivery (A) Scheme shows the maleimide chemistry conjugation strategy used to couple biotinylated LAMα1-p1 peptides to the cysteines in the agrin N-terminus (NtA-Ag) to create NtA-Ag-LAMα1-p1. (B) Western blot detects biotinylated proteins using horseradish peroxidase-coupled streptavidin with two lanes containing varying amounts of NtA-Ag, one lane of LAMα1-p1, and two lanes with varying amounts of NtA-Ag-LAMα1-p1. White arrows indicate the predicted size of NtA-Ag-LAMα1-p1. (C) Detection of biotin using fluorescent streptavidin in spots containing NtA-Ag-LAMα1-p1 or Nt-Ag on laminin 111-rich Matrigel coating. Scale bars = 500 μm. (D) Experimental design and scheme show the intramuscular injection of biotinylated NtA-Ag-LAMα1-p1. (E) Illustration shows the hypothetical presentation of candidate peptides to muscle stem cells by NtA-Ag in the skeletal muscle basal-lamina after injection. (F) Dystrophin immunostaining (dyst, green) of tibialis anterior (TA) cross sections from mice injected with NtA-Ag or biotinylated NtA-Ag-LAMα1-p1 co-stained with fluorophore-coupled streptavidin (red) and Hoechst DNA staining (blue). Scale bars = 10 μm.

    Journal: iScience

    Article Title: Identification of skeletal muscle stem cell adhesion motifs using spot-synthesis-based peptide arrays

    doi: 10.1016/j.isci.2025.114498

    Figure Lengend Snippet: In vivo peptide delivery (A) Scheme shows the maleimide chemistry conjugation strategy used to couple biotinylated LAMα1-p1 peptides to the cysteines in the agrin N-terminus (NtA-Ag) to create NtA-Ag-LAMα1-p1. (B) Western blot detects biotinylated proteins using horseradish peroxidase-coupled streptavidin with two lanes containing varying amounts of NtA-Ag, one lane of LAMα1-p1, and two lanes with varying amounts of NtA-Ag-LAMα1-p1. White arrows indicate the predicted size of NtA-Ag-LAMα1-p1. (C) Detection of biotin using fluorescent streptavidin in spots containing NtA-Ag-LAMα1-p1 or Nt-Ag on laminin 111-rich Matrigel coating. Scale bars = 500 μm. (D) Experimental design and scheme show the intramuscular injection of biotinylated NtA-Ag-LAMα1-p1. (E) Illustration shows the hypothetical presentation of candidate peptides to muscle stem cells by NtA-Ag in the skeletal muscle basal-lamina after injection. (F) Dystrophin immunostaining (dyst, green) of tibialis anterior (TA) cross sections from mice injected with NtA-Ag or biotinylated NtA-Ag-LAMα1-p1 co-stained with fluorophore-coupled streptavidin (red) and Hoechst DNA staining (blue). Scale bars = 10 μm.

    Article Snippet: After washing, the pellet was incubated with MACS streptavidin beads solution (1:200, 130-048-101, Miltenyi Biotec) for 1 h on ice.

    Techniques: In Vivo, Conjugation Assay, Western Blot, Injection, Immunostaining, Staining

    Adhesion peptides as biosensors (A) Scheme shows the detection strategy of biotinylated candidate adhesion peptides to visualize their cell surface binding. (B) Fluorescent streptavidin detection (green) of the different biotinylated candidate peptides bound to myoblasts in 2D culture in combination with Hoechst DNA staining to visualize DNA (blue). Myoblasts not incubated with peptide (No peptide) or exposed to the scrambled peptide sequences (SCR-p5) are shown as a control. Scale bar = 5 μm. (C) Integrin β1 (Itg-β1) immunostaining (red) of muscle stem cells (MuSCs) on single muscle fibers after 48 h of culture in combination with the fluorophore-coupled streptavidin detection of the different biotinylated candidate peptides (green) and Hoechst DNA staining (blue). Single fibers not incubated with peptide (No peptide) as well as one of the scrambled peptide sequences (SCR-p5) are shown as a control. Scale bar = 2 μm.

    Journal: iScience

    Article Title: Identification of skeletal muscle stem cell adhesion motifs using spot-synthesis-based peptide arrays

    doi: 10.1016/j.isci.2025.114498

    Figure Lengend Snippet: Adhesion peptides as biosensors (A) Scheme shows the detection strategy of biotinylated candidate adhesion peptides to visualize their cell surface binding. (B) Fluorescent streptavidin detection (green) of the different biotinylated candidate peptides bound to myoblasts in 2D culture in combination with Hoechst DNA staining to visualize DNA (blue). Myoblasts not incubated with peptide (No peptide) or exposed to the scrambled peptide sequences (SCR-p5) are shown as a control. Scale bar = 5 μm. (C) Integrin β1 (Itg-β1) immunostaining (red) of muscle stem cells (MuSCs) on single muscle fibers after 48 h of culture in combination with the fluorophore-coupled streptavidin detection of the different biotinylated candidate peptides (green) and Hoechst DNA staining (blue). Single fibers not incubated with peptide (No peptide) as well as one of the scrambled peptide sequences (SCR-p5) are shown as a control. Scale bar = 2 μm.

    Article Snippet: After washing, the pellet was incubated with MACS streptavidin beads solution (1:200, 130-048-101, Miltenyi Biotec) for 1 h on ice.

    Techniques: Binding Assay, Staining, Incubation, Control, Immunostaining